基于家庭的自我管理多模式的癌症干预和心脏毒性:一个范围审查
Anna Talty1, Roseanne Morris1, Carolyn Deighan2
1The Heart Manual Department, Astley Ainslie Hospital, Grange Loan, Edinburgh, Scotland, UK, EH9 2HL.
癌症幸存者护理正在增长,但整合心脏瘤学原则的干预措施是有限的. 心脏康复扩展是需要解决癌症幸存者的心脏健康需求.
科学领域:
- 心脏瘤学是一门专业.
- 癌症幸存者 护理 护理
- 心血管健康 心血管健康
背景情况:
- 越来越多的癌症幸存者经历了心血管疾病风险的增加.
- 癌症治疗的心脏毒性需要专门的护理.
- 现有的指导方针强调对幸存者护理的跨学科行动.
研究的目的:
- 进行现有癌症护理干预措施的范围审查.
- 评估如何将心脏瘤学原则纳入这些干预措施.
- 为了确定当前的幸存者护理实践的范围.
主要方法:
- 在PRISMA扩展后进行系统的文献搜索 (2010-2022年) 范围审查.
- 提取有关干预重点,交付,持续时间,方法和研究类型的数据.
- 根据预先定义的图表标准综合发现.
主要成果:
- 干预措施包括心理支持,体育活动,营养,教育,生活方式和护理人员支持.
- 许多研究仍处于协议或试点阶段 (仅有25%的研究进展).
- 没有一项确定的干预措施全面覆盖了所有六种模式,是可概括的,并纳入了心脏瘤学建议.
结论:
- 心脏瘤学指南建议尚未完全转化为实践.
- 在包括心脏健康在内的综合性幸存者护理中存在差距.
- 心脏康复服务应扩大以满足癌症幸存者的需求.
更多相关视频
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cardiovascular Drugs: Classification based on Therapeutic Indications
